Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinhart, S. C.
Right arrow Articles by Scheinman, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinhart, S. C.
Right arrow Articles by Scheinman, S. J.

Journal of the American Society of Nephrology, Vol 5, 1451-1461, Copyright © 1995 by American Society of Nephrology


REGULAR ARTICLES

Characterization of carrier females and affected males with X-linked recessive nephrolithiasis

SC Reinhart, AG Norden, M Lapsley, RV Thakker, J Pang, AM Moses, PA Frymoyer, MJ Favus, JA Hoepner and SJ Scheinman
Department of Medicine, SUNY Health Science Center, Syracuse 13210.

X-linked recessive nephrolithiasis (XRN) was described in a large kindred in which nephrolithiasis; proximal tubular dysfunction, proteinuria, nephrocalcinosis, and renal failure occur only in males. Carrier females are asymptomatic, but formal studies of them have not been done. The gene for XRN has been mapped to the pericentromeric region of the X chromosome, close to the loci for several eye disease genes. We studied six affected males, 13 carrier females, and 25 normal members of this family including 7 females whose genetic haplotype predicted them to be carriers. Studies were done in the Clinical Research Unit on a diet containing 400 mg of calcium and 2 g of sodium, and by an additional outpatient urine collection was obtained on a 1-g calcium intake. Hypercalciuria occurred in five of six affected males, 4 of 12 carrier females, and three of seven predicted carriers. Significant proteinuria was present in all affected males and in no other subjects. Low-molecular-weight proteinuria was present in all affected males: the excretion of alpha 1-microglobulin exceeded normal by 3- to 14-fold, of beta 2-microglobulin exceeded normal by 100- to 400-fold, and of retinol-binding protein exceeded normal by 1,000- to 3,000-fold. The excretion of these proteins was less strikingly elevated in carrier females, but the excretion of alpha 1-microglobulin was abnormal in 9 of 15 carriers, beta 2-microglobulin was abnormal in 12 of 15, and retinolbinding protein in was abnormal 12 of 13, and this pattern was similar in predicted carriers. The urinary concentrating ability was abnormal in four affected males with renal insufficiency but normal in all other subjects. Urinary wasting of potassium, phosphorous, and glucose occurred infrequently, and no subject was hypouricemic. Formal ophthalmologic studies were normal in five affected males. Thus, the most consistent urinary abnormalities in XRN are hypercalciuria and low-molecular-weight proteinuria, the latter of which appears to be a marker for the carrier state.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Ludwig, B. Utsch, and L. A. H. Monnens
Recent advances in understanding the clinical and genetic heterogeneity of Dent's disease
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2708 - 2717.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Tosetto, G. M. Ghiggeri, F. Emma, G. Barbano, A. Carrea, G. Vezzoli, R. Torregrossa, M. Cara, G. Ripanti, A. Ammenti, et al.
Phenotypic and genetic heterogeneity in Dent's disease--the results of an Italian collaborative study
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2452 - 2463.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. A Raja, S. Schurman, R. G. D'Mello, D. Blowey, P. Goodyer, S. Van Why, R. J. Ploutz-Snyder, J. Asplin, and S. J. Scheinman
Responsiveness of Hypercalciuria to Thiazide in Dent's Disease
J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2938 - 2944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. Devuyst and W. B. Guggino
Chloride channels in the kidney: lessons learned from knockout animals
Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1176 - F1191.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. S. Wang, O. Devuyst, P. J. Courtoy, X.-T. Wang, H. Wang, Y. Wang, R. V. Thakker, S. Guggino, and W. B. Guggino
Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis
Hum. Mol. Genet., December 1, 2000; 9(20): 2937 - 2945.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Uchida
In vivo role of CLC chloride channels in the kidney
Am J Physiol Renal Physiol, November 1, 2000; 279(5): F802 - F808.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. YAMAMOTO, J. P. D. T. COX, T. FRIEDRICH, P. T. CHRISTIE, M. BALD, P. N. HOUTMAN, M. J. LAPSLEY, L. PATZER, M. TSIMARATOS, W. G VAN'T HOFF, et al.
Characterization of Renal Chloride Channel (CLCN5) Mutations in Dent's Disease
J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1460 - 1468.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
S. WALDEGGER and T. J. JENTSCH
From Tonus to Tonicity: Physiology of CLC Chloride Channels
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1331 - 1339.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. A. Luyckx, B. Leclercq, L. K. Dowland, and A. S. L. Yu
Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression
PNAS, October 12, 1999; 96(21): 12174 - 12179.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. J. Scheinman, L. M. Guay-Woodford, R. V. Thakker, and D. G. Warnock
Genetic Disorders of Renal Electrolyte Transport
N. Engl. J. Med., April 15, 1999; 340(15): 1177 - 1187.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. A. Luyckx, F. O. Goda, D. B. Mount, T. Nishio, A. Hall, S. C. Hebert, T. G. Hammond, and A. S. L. Yu
Intrarenal and subcellular localization of rat CLC5
Am J Physiol Renal Physiol, November 1, 1998; 275(5): F761 - F769.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Gunther, A. Luchow, F. Cluzeaud, A. Vandewalle, and T. J. Jentsch
ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells
PNAS, July 7, 1998; 95(14): 8075 - 8080.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP